Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug;79(8):819-836.
doi: 10.1002/dneu.22710. Epub 2019 Jul 25.

Models and treatments for traumatic optic neuropathy and demyelinating optic neuritis

Affiliations
Review

Models and treatments for traumatic optic neuropathy and demyelinating optic neuritis

George G Bastakis et al. Dev Neurobiol. 2019 Aug.

Abstract

Pathologies of the optic nerve could result as primary insults in the visual tract or as secondary deficits due to inflammation, demyelination, or compressing effects of the surrounding tissue. The extent of damage may vary from mild to severe, differently affecting patient vision, with the most severe forms leading to complete uni- or bilateral visual loss. The aim of researchers and clinicians in the field is to alleviate the symptoms of these, yet uncurable pathologies, taking advantage of known and novel potential therapeutic approaches, alone or in combinations, and applying them in a limited time window after the insult. In this review, we discuss the epidemiological and clinical profile as well as the pathophysiological mechanisms of two main categories of optic nerve pathologies, namely traumatic optic neuropathy and optic neuritis, focusing on the demyelinating form of the latter. Moreover, we report on the main rodent models mimicking these pathologies or some of their clinical aspects. The current treatment options will also be reviewed and novel approaches will be discussed.

Keywords: neuronal survival; optic nerve; regeneration; retinal ganglion cells.

PubMed Disclaimer

References

REFERENCES

    1. Abraham, I. M., Harkany, T., Horvath, K. M., & Luiten, P. G. (2001). Action of glucocorticoids on survival of nerve cells: Promoting neurodegeneration or neuroprotection? Journal of Neuroendocrinology, 13(9), 749-760.
    1. ALS CNTF Treatment Study Group. (1996). A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. Neurology, 46(5), 1244-1249.
    1. Anderson, R. L., Panje, W. R., & Gross, C. E. (1982). Optic nerve blindness following blunt forehead trauma. Ophthalmology, 89(5), 445-455. https://doi.org/10.1016/S0161-6420(82)34769-7
    1. Araújo, S. E. S., Mendonça, H. R., Wheeler, N. A., Campello-Costa, P., Jacobs, K. M., Gomes, F. C. A., … Fuss, B. (2017). Inflammatory demyelination alters subcortical visual circuits. Journal of Neuroinflammation, 14(1), 162. https://doi.org/10.1186/s12974-017-0936-0
    1. Beck, R. W. (1995). The optic neuritis treatment trial: Three-year follow-up results. Archives of Ophthalmology, 113(2), 136-137. https://doi.org/10.1001/archopht.1995.01100020014004

Publication types

MeSH terms

LinkOut - more resources